The metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling-tandem mass spectrometry method
Abstract Evidence suggests that β-secretase (BACE1), which cleaves Amyloid Precursor Protein (APP) to form sAPPβ and amyloid-β, is elevated in Alzheimer's disease (AD) brains and biofluids and, thus, BACE1 is a therapeutic target for this devastating disease. The direct product of BACE1 cleavag...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2022-09-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-022-18869-3 |
| _version_ | 1817994009875841024 |
|---|---|
| author | Justyna A. Dobrowolska Zakaria Randall J. Bateman Monika Lysakowska Ammaarah Khatri Dinorah Jean-Gilles Matthew E. Kennedy Robert Vassar |
| author_facet | Justyna A. Dobrowolska Zakaria Randall J. Bateman Monika Lysakowska Ammaarah Khatri Dinorah Jean-Gilles Matthew E. Kennedy Robert Vassar |
| author_sort | Justyna A. Dobrowolska Zakaria |
| collection | DOAJ |
| description | Abstract Evidence suggests that β-secretase (BACE1), which cleaves Amyloid Precursor Protein (APP) to form sAPPβ and amyloid-β, is elevated in Alzheimer's disease (AD) brains and biofluids and, thus, BACE1 is a therapeutic target for this devastating disease. The direct product of BACE1 cleavage of APP, sAPPβ, serves as a surrogate marker of BACE1 activity in the central nervous system. This biomarker could be utilized to better understand normal APP processing, aberrant processing in the disease setting, and modulations to processing during therapeutic intervention. In this paper, we present a method for measuring the metabolism of sAPPβ and another APP proteolytic product, sAPPα, in vivo in humans using stable isotope labeling kinetics, paired with immunoprecipitation and liquid chromatography/tandem mass spectrometry. The method presented herein is robust, reproducible, and precise, and allows for the study of these analytes by taking into account their full dynamic potential as opposed to the traditional methods of absolute concentration quantitation that only provide a static view of a dynamic system. A study of in vivo cerebrospinal fluid sAPPβ and sAPPα kinetics using these methods could reveal novel insights into pathophysiological mechanisms of AD, such as increased BACE1 processing of APP. |
| first_indexed | 2024-04-14T01:47:19Z |
| format | Article |
| id | doaj.art-e920bdebd0534dcca97073affc0fb225 |
| institution | Directory Open Access Journal |
| issn | 2045-2322 |
| language | English |
| last_indexed | 2024-04-14T01:47:19Z |
| publishDate | 2022-09-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj.art-e920bdebd0534dcca97073affc0fb2252022-12-22T02:19:30ZengNature PortfolioScientific Reports2045-23222022-09-0112111210.1038/s41598-022-18869-3The metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling-tandem mass spectrometry methodJustyna A. Dobrowolska Zakaria0Randall J. Bateman1Monika Lysakowska2Ammaarah Khatri3Dinorah Jean-Gilles4Matthew E. Kennedy5Robert Vassar6Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of MedicineDepartment of Neurology, Washington University School of MedicineKen and Ruth Davee Department of Neurology, Northwestern University Feinberg School of MedicineKen and Ruth Davee Department of Neurology, Northwestern University Feinberg School of MedicineDeparment of Neuroscience, Merck & Co., Inc.Deparment of Neuroscience, Merck & Co., Inc.Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of MedicineAbstract Evidence suggests that β-secretase (BACE1), which cleaves Amyloid Precursor Protein (APP) to form sAPPβ and amyloid-β, is elevated in Alzheimer's disease (AD) brains and biofluids and, thus, BACE1 is a therapeutic target for this devastating disease. The direct product of BACE1 cleavage of APP, sAPPβ, serves as a surrogate marker of BACE1 activity in the central nervous system. This biomarker could be utilized to better understand normal APP processing, aberrant processing in the disease setting, and modulations to processing during therapeutic intervention. In this paper, we present a method for measuring the metabolism of sAPPβ and another APP proteolytic product, sAPPα, in vivo in humans using stable isotope labeling kinetics, paired with immunoprecipitation and liquid chromatography/tandem mass spectrometry. The method presented herein is robust, reproducible, and precise, and allows for the study of these analytes by taking into account their full dynamic potential as opposed to the traditional methods of absolute concentration quantitation that only provide a static view of a dynamic system. A study of in vivo cerebrospinal fluid sAPPβ and sAPPα kinetics using these methods could reveal novel insights into pathophysiological mechanisms of AD, such as increased BACE1 processing of APP.https://doi.org/10.1038/s41598-022-18869-3 |
| spellingShingle | Justyna A. Dobrowolska Zakaria Randall J. Bateman Monika Lysakowska Ammaarah Khatri Dinorah Jean-Gilles Matthew E. Kennedy Robert Vassar The metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling-tandem mass spectrometry method Scientific Reports |
| title | The metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling-tandem mass spectrometry method |
| title_full | The metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling-tandem mass spectrometry method |
| title_fullStr | The metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling-tandem mass spectrometry method |
| title_full_unstemmed | The metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling-tandem mass spectrometry method |
| title_short | The metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling-tandem mass spectrometry method |
| title_sort | metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling tandem mass spectrometry method |
| url | https://doi.org/10.1038/s41598-022-18869-3 |
| work_keys_str_mv | AT justynaadobrowolskazakaria themetabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT randalljbateman themetabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT monikalysakowska themetabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT ammaarahkhatri themetabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT dinorahjeangilles themetabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT matthewekennedy themetabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT robertvassar themetabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT justynaadobrowolskazakaria metabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT randalljbateman metabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT monikalysakowska metabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT ammaarahkhatri metabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT dinorahjeangilles metabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT matthewekennedy metabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod AT robertvassar metabolismofhumansolubleamyloidprecursorproteinisoformsisquantifiablebyastableisotopelabelingtandemmassspectrometrymethod |